HighTower Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-90,000
Closed -$78K 3970
2024
Q4
$78K Buy
+90,000
New +$2.44M ﹤0.01% 3413
2024
Q3
Sell
-2,800
Closed -$58 3911
2024
Q2
$58 Buy
+2,800
New +$77.1K ﹤0.01% 3645
2024
Q1
Sell
-1,000
Closed -$2.81K 3907
2023
Q4
$2.81K Buy
1,000
+960
+2,400% +$29K ﹤0.01% 3497
2023
Q3
$2.92K Buy
+40
New +$1.42K ﹤0.01% 3452
2023
Q2
Sell
-5,100
Closed -$4.08K 3623
2023
Q1
$4.08K Buy
5,100
+5,005
+5,268% +$216K ﹤0.01% 3246
2022
Q4
$3.65K Buy
95
+10
+12% +$479 ﹤0.01% 3237
2022
Q3
$19K Sell
85
-8,015
-99% -$389K ﹤0.01% 2977
2022
Q2
$12K Buy
8,100
+8,019
+9,900% +$409K ﹤0.01% 3049
2022
Q1
$14K Buy
81
+49
+153% +$2.54K ﹤0.01% 3195
2021
Q4
$78K Sell
32
-31,868
-100% -$1.58M ﹤0.01% 2967
2021
Q3
$11K Buy
+31,900
New +$1.41M ﹤0.01% 3034
2021
Q2
Sell
-100
Closed -$9K 3329
2021
Q1
$9K Buy
100
+60
+150% +$2.13K ﹤0.01% 2935
2020
Q4
$1K Buy
+40
New +$1.47K ﹤0.01% 2583
2016
Q1
Sell
-104,451
Closed -$4K 2170
2015
Q4
$4K Buy
+104,451
New +$3.29M ﹤0.01% 2012

Other funds holding PFE

HighTower Advisors's PFE Position: Q1 2026 in Review

HighTower Advisors increased its Pfizer (PFE) stake by 1.4% in Q1 2026, buying an estimated $973K and bringing the position to 2,648,143 shares worth $74.4M. The position accounts for 0.08% of the portfolio, ranked #250.

HighTower Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $236M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • HighTower Advisors held 2,648,143 shares of Pfizer worth $74.4M as of Q1 2026.
  • HighTower Advisors bought 36,533 Pfizer shares in Q1 2026, an estimated $973K.
  • Pfizer made up 0.08% of HighTower Advisors's portfolio in Q1 2026, its #250 holding.
  • HighTower Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Pfizer position peaked at $236M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.